Brochure
2 Oct 2020

Surflo Winged Infusion Sets (with Filter) and Needle Protection, designed for comfort

PDF 733 kB

Our Surflo®️ portfolio incorporates the best of Terumo’s needle technology:

  • Triple bevel for smooth skin penetration
  • Interlocking, slightly angled wings for stability and grip
  • Flexible tubing for a consistent flow
  • Surshield®️ safety shield to reduce the risk of NSIs
  • Microbore tubing available to reduce the dead space volume
  • Optional, integrated 20µm filter
  • Content provided by our supplier

    Terumo Europe NV - TPS

    • BE
    • 2015
      On CPhI since
    • 3
      Certificates
    • 500 - 999
      Employees
    Company types
    Manufacturer/Innovator
    Primary activities
    Medical Devices

    Other Content from Terumo Europe NV - TPS

    • News Terumo Enters 100th Anniversary Year

      Terumo Corporation (TSE: 4543) is celebrating its 100th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021. The company has established 'Stride Ahead' as a slogan, to celebrate and connect all Terumo associates around the world. The phrase encompasses the company's belief that big steps forward will lead to a better future for healthcare.
    • Brochure Technology for today and tomorrow. Think Terumo.

      Our PLAJEX primary packaging solutions offer the functionality and compatibility needed to deliver today’s most challenging biologics and parenteral drug products.
    • News Terumo’s PLAJEX Provides a Solution for a New Osteoporosis Treatment Developed and Manufactured on Contract

      Terumo Corporation (TSE: 4543) today announced that a new osteoporosis medication, Teribone
      Asahi Kasei Pharma has been providing lyophilized vial formulation Teribone

    • Brochure Ready-to-fill Polymer syringes and had-case needles

      From the pioneer to the pacesetter for hard-case needles used in hypodermic drug application. Our K-Pack II needles have been designed for co-packing needs and have been crafted to deliver a better patient experience.
    • News Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

      - Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO -
      As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...

    • News Terumo’s PLAJEX™ Enters the US Market by Receiving GMP Certification from FDA to Manufacture Biosimilar Hulio

      Terumo Corporation (TSE: 4543) announced that its affiliate company Terumo Yamaguchi D&D Corporation has received Good Manufacturing Practice (GMP) certification from the US Food and Drug Administration (FDA), in regards to a bio...

    • Brochure We listen. We question. We deliver.

      Comprehensive parenteral delivery product portfolio: Pioneering hypodermic needle innovation designed for patient comfort. More confident, comfortable infusions. Ready to fill polymer syringes, ready for breakthrough formulations and demanding fill & finish processing environments.
    • News Terumo Pharmaceutical Solutions wins 2019 Asia-Pacific Industry Award

      Tokyo-based Terumo Pharmaceutical Solutions has been awarded the Asia-Pacific Bioprocessing Excellence Award 2019 at the 6th Biologics Manufacturing Asia & 3rd Bio logistics World Asia 2019 conferences in Singapore.
    • Brochure Extra-Thin Wall & Ultra-Thin Wall Technology for enhanced control and improved patient experience

      Terumo’s needle technology helps to use a higher gauge needle without having to compromise on performance. The advantages of the extra-& ultra-thin-wall features are: - Reduced delivery time due to higher flow rates when compared to regular wall type cannulas - Reduced extrusion forces as a result of lower flow resistance – for regular and for high viscosities All aiming to improve patient experience!
    • Video Self-infusion takes great courage; most people with hemophilia do it three times a week for the rest of their lives

      Among inherited blood disorders, hemophilia is often diagnosed early in childhood. Its debilitating symptoms afflict approximately 400,000 worldwide* and takes tremendous effort to treat effectively: Treatment includes frequent infusions Patients as young as eight must learn to treat themselves Requires scrupulous patient dose compliance For young patients it takes real courage to stick themselves with a needle, let alone the responsibility of doing it as many as three times a week. It’s a badge of courage they wear on the inside for the rest of their lives. Terumo Pharmaceutical Solutions felt they should have one to wear on the outside – something to let the world know how brave they really are.
    • Video Terumo Pharmaceutical Solutions. Our story.

      At Terumo Pharmaceutical Solutions, developing effective drug delivery devices is a true craft. It requires experience in medical technology for pharmaceuticals. The care and precision we put in the development of our products comes from our Japanese background.
    • Video Pathway To Overcome Primary Packaging & Drug Product Manufacturing (F&F) Challenges: Case Study, Ophthalmic Drugs

      This webinar will address: The global ophthalmic drug market is forecasted to reach $47.6 billion by 2030 with a growth driven by the rapidly ageing global population. Silicon oil-free technology contributes to achieve low subvisible particles and enable consistent and predictable glide forces for a better drug product system. The collaboration on fill & finish processes and primary containers contribute to improve filling accuracy, minimize headspace and maximize throughput while ensuring flexibility and time to market. Established collaboration such as Terumo and Swissfillon offers a best-in-class solution for ophthalmic projects This webinar originally aired as part of Pharmapack Europe 2021
    • Video Surflo™ Winged Infusion Sets with or without needle protection

      Surflo™ Winged Infusion Sets with Needle Protection offer precision, stability, and the needlestick prevention needed to deliver today’s most advanced therapeutics safely and confidently. 
      More Confident, Comfortable InfusionsIntegrating the best of Terumo Pharmaceutical Solutions’ needle technology with interlocking color-coded wings, Surflo® Winged Infusion Sets with Needle Protection (Surshield®) offer a simple needlestick prevention device with Terumo’s industry-leading T-SharpTM lancet design that reduces penetration pain¹.Surflo® Winged Infusion Sets Needle Protection (Surshield®) offer the quality and supply reliability drug developers need to meet parenteral delivery challenges and product commercialization goals.
    • Video PLAJEX TM Ready-to-Fill Polymer Syringe with Tapered Needle

      The PLAJEX TM Tapered Needle is designed for better injectability without compromising patient comfort. Resistance to flow can be reduced by using a conically-shaped needle with small diameter at the tip and a larger diameter at the bottom.